Answers are grounded in this paper and cite their sources.
A 40-year-old man with cervical dystonia developed an acute inflammatory demyelinating polyradiculoneuritis after botulinum toxin type A treatment. Some cases of idiopathic brachial plexopathy and polyradiculoneuritis have been reported to date. Although a causal relationship is not firmly established, the clinical temporal profile suggests a pathogenic relationship. In patients with cervical dystonia, further use of type A botulinum toxin should be considered contraindicated, and the use of another type of botulinum toxin should be taken into consideration.
No takes yet. Share an insight, caveat, or question.
Burguera et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: